Ovid Therapeutics News - OVID

Company Name	Stock Ticker Symbol	Market	Type
Ovid Therapeutics Inc	OVID	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.16	-5.08%	2.99	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
3.13	2.99	3.14	2.99	3.15

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/04/2024	08:00	GLOBE	Ovid Therapeutics to Present at the 23rd Annual Needham..
3/08/2024	08:24	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/08/2024	08:20	EDGAR2	Form 8-K - Current report
3/08/2024	08:00	GLOBE	Ovid Therapeutics Reports Business Updates, Fourth Quarter..
2/28/2024	08:00	GLOBE	Ovid Therapeutics to Present at the TD Cowen 44th Annual..
2/26/2024	18:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	17:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	17:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	11:10	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	06:06	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/06/2024	08:00	GLOBE	Ovid Therapeutics to Present at the Oppenheimer 34th Annual..
12/06/2023	17:08	EDGAR2	Form 8-K - Current report
12/01/2023	07:30	GLOBE	Ovid Therapeutics to Present Five Abstracts Supporting its..
11/16/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/15/2023	16:11	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/03/2023	16:08	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/03/2023	08:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/2023	08:10	EDGAR2	Form 8-K - Current report
11/03/2023	08:00	GLOBE	Ovid Therapeutics Reports Third Quarter 2023 Financial..
10/18/2023	08:04	EDGAR2	Form 8-K - Current report
10/18/2023	08:00	GLOBE	Ovid Therapeutics and Ligand Pharmaceuticals Enter into a..
10/10/2023	08:00	GLOBE	Ovid Therapeutics to Present at the Jefferies Biotech..
10/02/2023	12:15	EDGAR2	Form 8-K - Current report
9/26/2023	07:30	GLOBE	Ovid Therapeutics to Host Investor Event - R&D Day on..
9/20/2023	07:30	GLOBE	Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald..
8/30/2023	08:00	GLOBE	Ovid Therapeutics to Participate in Upcoming September..
8/04/2023	09:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/04/2023	09:10	EDGAR2	Form 8-K - Current report
8/04/2023	08:00	GLOBE	Ovid Therapeutics Reports Second Quarter 2023 Financial..
8/01/2023	08:00	GLOBE	Ovid Therapeutics to Present at the BTIG Virtual..
7/31/2023	17:21	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
6/28/2023	08:00	GLOBE	Ovid Therapeutics Expands Its Scientific Leadership Team &..
6/26/2023	08:00	GLOBE	Ovid Therapeutics Added to Russell 3000® Index
5/05/2023	07:30	GLOBE	Ovid Therapeutics Reports First Quarter 2023 Financial..
5/01/2023	06:00	GLOBE	Ovid Therapeutics Announces Collaboration with Graviton..
4/27/2023	14:30	GLOBE	Long-term Safety & Efficacy Findings from Soticlestat Open..